Frailty-stratified randomised controlled bayesian adaptive trial of bortezomib versus lenalidomide in transplant-ineligible myeloma - the FRAIL-M study (MRFF LSCD Grant Administered by Monash) (2019-2023)
Experts
Professor
Ruth Hubbard
Affiliate of Centre for Healthy Ageing Innovation
Centre for Healthy Ageing Innovation
Faculty of Health, Medicine and Behavioural Sciences
Masonic Chair of Geriatric Medicine
Frazer Institute
Faculty of Health, Medicine and Behavioural Sciences
